nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—NT5E—periosteum—sarcoma	0.0604	0.136	CbGeAlD
Pentoxifylline—PDE5A—pulmonary artery—sarcoma	0.0461	0.104	CbGeAlD
Pentoxifylline—NT5E—cartilage tissue—sarcoma	0.0423	0.0956	CbGeAlD
Pentoxifylline—NT5E—mammary gland—sarcoma	0.0179	0.0405	CbGeAlD
Pentoxifylline—PDE5A—endothelium—sarcoma	0.0144	0.0326	CbGeAlD
Pentoxifylline—PDE4A—mammary gland—sarcoma	0.0137	0.0309	CbGeAlD
Pentoxifylline—NT5E—myometrium—sarcoma	0.0127	0.0288	CbGeAlD
Pentoxifylline—NT5E—embryo—sarcoma	0.0122	0.0277	CbGeAlD
Pentoxifylline—NT5E—hematopoietic system—sarcoma	0.0109	0.0247	CbGeAlD
Pentoxifylline—NT5E—connective tissue—sarcoma	0.0105	0.0238	CbGeAlD
Pentoxifylline—NT5E—smooth muscle tissue—sarcoma	0.00963	0.0217	CbGeAlD
Pentoxifylline—NT5E—skin of body—sarcoma	0.0095	0.0215	CbGeAlD
Pentoxifylline—NT5E—cardiac atrium—sarcoma	0.0083	0.0188	CbGeAlD
Pentoxifylline—NT5E—uterus—sarcoma	0.00826	0.0187	CbGeAlD
Pentoxifylline—ADORA2B—smooth muscle tissue—sarcoma	0.00824	0.0186	CbGeAlD
Pentoxifylline—ADORA2A—hematopoietic system—sarcoma	0.00779	0.0176	CbGeAlD
Pentoxifylline—NT5E—lymphoid tissue—sarcoma	0.0077	0.0174	CbGeAlD
Pentoxifylline—NT5E—tendon—sarcoma	0.00723	0.0163	CbGeAlD
Pentoxifylline—PDE5A—hematopoietic system—sarcoma	0.00709	0.016	CbGeAlD
Pentoxifylline—NT5E—bone marrow—sarcoma	0.00701	0.0158	CbGeAlD
Pentoxifylline—PDE5A—connective tissue—sarcoma	0.00683	0.0154	CbGeAlD
Pentoxifylline—ADORA1—hematopoietic system—sarcoma	0.00672	0.0152	CbGeAlD
Pentoxifylline—PDE5A—smooth muscle tissue—sarcoma	0.00625	0.0141	CbGeAlD
Pentoxifylline—NT5E—testis—sarcoma	0.00599	0.0135	CbGeAlD
Pentoxifylline—NT5E—liver—sarcoma	0.00566	0.0128	CbGeAlD
Pentoxifylline—ADORA2A—lymphoid tissue—sarcoma	0.00548	0.0124	CbGeAlD
Pentoxifylline—ADORA2B—testis—sarcoma	0.00513	0.0116	CbGeAlD
Pentoxifylline—ADORA1—cardiac atrium—sarcoma	0.00511	0.0115	CbGeAlD
Pentoxifylline—PDE4B—hematopoietic system—sarcoma	0.00497	0.0112	CbGeAlD
Pentoxifylline—PDE5A—tendon—sarcoma	0.00469	0.0106	CbGeAlD
Pentoxifylline—PDE4A—testis—sarcoma	0.00457	0.0103	CbGeAlD
Pentoxifylline—ADORA1—tendon—sarcoma	0.00445	0.0101	CbGeAlD
Pentoxifylline—NT5E—lymph node—sarcoma	0.00434	0.00981	CbGeAlD
Pentoxifylline—ADORA2A—testis—sarcoma	0.00427	0.00964	CbGeAlD
Pentoxifylline—ADORA2A—liver—sarcoma	0.00403	0.00912	CbGeAlD
Pentoxifylline—PDE5A—testis—sarcoma	0.00389	0.00878	CbGeAlD
Pentoxifylline—PDE4B—cardiac atrium—sarcoma	0.00378	0.00853	CbGeAlD
Pentoxifylline—ADORA1—testis—sarcoma	0.00369	0.00833	CbGeAlD
Pentoxifylline—PDE4B—lymphoid tissue—sarcoma	0.0035	0.00791	CbGeAlD
Pentoxifylline—PDE4A—lymph node—sarcoma	0.00331	0.00749	CbGeAlD
Pentoxifylline—PDE4B—tendon—sarcoma	0.00329	0.00744	CbGeAlD
Pentoxifylline—PDE4B—bone marrow—sarcoma	0.00319	0.0072	CbGeAlD
Pentoxifylline—CYP1A2—hematopoietic system—sarcoma	0.00306	0.0069	CbGeAlD
Pentoxifylline—PDE5A—lymph node—sarcoma	0.00282	0.00637	CbGeAlD
Pentoxifylline—PDE4B—testis—sarcoma	0.00273	0.00616	CbGeAlD
Pentoxifylline—ADORA1—lymph node—sarcoma	0.00267	0.00603	CbGeAlD
Pentoxifylline—PDE4B—liver—sarcoma	0.00258	0.00582	CbGeAlD
Pentoxifylline—PDE4B—lymph node—sarcoma	0.00198	0.00446	CbGeAlD
Pentoxifylline—CYP1A2—liver—sarcoma	0.00158	0.00358	CbGeAlD
Pentoxifylline—Anorexia—Vincristine—sarcoma	0.00142	0.00283	CcSEcCtD
Pentoxifylline—Tachycardia—Mitoxantrone—sarcoma	0.00141	0.00282	CcSEcCtD
Pentoxifylline—Skin disorder—Mitoxantrone—sarcoma	0.00141	0.00281	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Mitoxantrone—sarcoma	0.0014	0.0028	CcSEcCtD
Pentoxifylline—Hypotension—Vincristine—sarcoma	0.00139	0.00278	CcSEcCtD
Pentoxifylline—Feeling abnormal—Thiotepa—sarcoma	0.00138	0.00276	CcSEcCtD
Pentoxifylline—Anorexia—Mitoxantrone—sarcoma	0.00138	0.00276	CcSEcCtD
Pentoxifylline—Feeling abnormal—Dactinomycin—sarcoma	0.00137	0.00274	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Thiotepa—sarcoma	0.00137	0.00274	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Etoposide—sarcoma	0.00137	0.00273	CcSEcCtD
Pentoxifylline—Anaemia—Etoposide—sarcoma	0.00137	0.00272	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Dactinomycin—sarcoma	0.00136	0.00272	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Vincristine—sarcoma	0.00136	0.00271	CcSEcCtD
Pentoxifylline—Hypotension—Mitoxantrone—sarcoma	0.00135	0.0027	CcSEcCtD
Pentoxifylline—Insomnia—Vincristine—sarcoma	0.00135	0.00269	CcSEcCtD
Pentoxifylline—Urticaria—Thiotepa—sarcoma	0.00133	0.00266	CcSEcCtD
Pentoxifylline—Malaise—Etoposide—sarcoma	0.00133	0.00266	CcSEcCtD
Pentoxifylline—Abdominal pain—Thiotepa—sarcoma	0.00133	0.00265	CcSEcCtD
Pentoxifylline—Body temperature increased—Thiotepa—sarcoma	0.00133	0.00265	CcSEcCtD
Pentoxifylline—Leukopenia—Etoposide—sarcoma	0.00132	0.00264	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00132	0.00263	CcSEcCtD
Pentoxifylline—Purpura—Doxorubicin—sarcoma	0.00132	0.00263	CcSEcCtD
Pentoxifylline—Body temperature increased—Dactinomycin—sarcoma	0.00132	0.00263	CcSEcCtD
Pentoxifylline—Abdominal pain—Dactinomycin—sarcoma	0.00132	0.00263	CcSEcCtD
Pentoxifylline—Anaphylactoid reaction—Doxorubicin—sarcoma	0.00131	0.00262	CcSEcCtD
Pentoxifylline—Decreased appetite—Vincristine—sarcoma	0.00129	0.00258	CcSEcCtD
Pentoxifylline—Dyspnoea—Mitoxantrone—sarcoma	0.00129	0.00258	CcSEcCtD
Pentoxifylline—Somnolence—Mitoxantrone—sarcoma	0.00129	0.00257	CcSEcCtD
Pentoxifylline—Convulsion—Etoposide—sarcoma	0.00128	0.00255	CcSEcCtD
Pentoxifylline—Dyspepsia—Mitoxantrone—sarcoma	0.00128	0.00255	CcSEcCtD
Pentoxifylline—Hypertension—Etoposide—sarcoma	0.00128	0.00254	CcSEcCtD
Pentoxifylline—Constipation—Vincristine—sarcoma	0.00127	0.00254	CcSEcCtD
Pentoxifylline—Decreased appetite—Mitoxantrone—sarcoma	0.00126	0.00251	CcSEcCtD
Pentoxifylline—Chest pain—Etoposide—sarcoma	0.00126	0.00251	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00125	0.00249	CcSEcCtD
Pentoxifylline—Discomfort—Etoposide—sarcoma	0.00124	0.00248	CcSEcCtD
Pentoxifylline—Constipation—Mitoxantrone—sarcoma	0.00124	0.00247	CcSEcCtD
Pentoxifylline—Hypersensitivity—Thiotepa—sarcoma	0.00124	0.00247	CcSEcCtD
Pentoxifylline—Hypersensitivity—Dactinomycin—sarcoma	0.00123	0.00245	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Vincristine—sarcoma	0.00122	0.00243	CcSEcCtD
Pentoxifylline—Confusional state—Etoposide—sarcoma	0.00122	0.00243	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Etoposide—sarcoma	0.00121	0.00241	CcSEcCtD
Pentoxifylline—Asthenia—Thiotepa—sarcoma	0.0012	0.0024	CcSEcCtD
Pentoxifylline—Infection—Etoposide—sarcoma	0.0012	0.00239	CcSEcCtD
Pentoxifylline—Abdominal distension—Epirubicin—sarcoma	0.0012	0.00239	CcSEcCtD
Pentoxifylline—Asthenia—Dactinomycin—sarcoma	0.0012	0.00238	CcSEcCtD
Pentoxifylline—Feeling abnormal—Mitoxantrone—sarcoma	0.00119	0.00238	CcSEcCtD
Pentoxifylline—Pruritus—Thiotepa—sarcoma	0.00119	0.00237	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00119	0.00236	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Etoposide—sarcoma	0.00118	0.00236	CcSEcCtD
Pentoxifylline—Tachycardia—Etoposide—sarcoma	0.00118	0.00235	CcSEcCtD
Pentoxifylline—Body temperature increased—Vincristine—sarcoma	0.00118	0.00235	CcSEcCtD
Pentoxifylline—Abdominal pain—Vincristine—sarcoma	0.00118	0.00235	CcSEcCtD
Pentoxifylline—Skin disorder—Etoposide—sarcoma	0.00117	0.00234	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Etoposide—sarcoma	0.00117	0.00233	CcSEcCtD
Pentoxifylline—Angina pectoris—Epirubicin—sarcoma	0.00116	0.00231	CcSEcCtD
Pentoxifylline—Urticaria—Mitoxantrone—sarcoma	0.00115	0.0023	CcSEcCtD
Pentoxifylline—Anorexia—Etoposide—sarcoma	0.00115	0.00229	CcSEcCtD
Pentoxifylline—Diarrhoea—Thiotepa—sarcoma	0.00115	0.00229	CcSEcCtD
Pentoxifylline—Abdominal pain—Mitoxantrone—sarcoma	0.00115	0.00229	CcSEcCtD
Pentoxifylline—Body temperature increased—Mitoxantrone—sarcoma	0.00115	0.00229	CcSEcCtD
Pentoxifylline—Diarrhoea—Dactinomycin—sarcoma	0.00114	0.00227	CcSEcCtD
Pentoxifylline—Pancytopenia—Epirubicin—sarcoma	0.00113	0.00225	CcSEcCtD
Pentoxifylline—Hypotension—Etoposide—sarcoma	0.00113	0.00225	CcSEcCtD
Pentoxifylline—Dizziness—Thiotepa—sarcoma	0.00111	0.00221	CcSEcCtD
Pentoxifylline—Abdominal distension—Doxorubicin—sarcoma	0.00111	0.00221	CcSEcCtD
Pentoxifylline—Hypersensitivity—Vincristine—sarcoma	0.0011	0.00219	CcSEcCtD
Pentoxifylline—Dyspnoea—Etoposide—sarcoma	0.00108	0.00214	CcSEcCtD
Pentoxifylline—Somnolence—Etoposide—sarcoma	0.00107	0.00214	CcSEcCtD
Pentoxifylline—Angina pectoris—Doxorubicin—sarcoma	0.00107	0.00214	CcSEcCtD
Pentoxifylline—Hypersensitivity—Mitoxantrone—sarcoma	0.00107	0.00213	CcSEcCtD
Pentoxifylline—Asthenia—Vincristine—sarcoma	0.00107	0.00213	CcSEcCtD
Pentoxifylline—Vomiting—Thiotepa—sarcoma	0.00107	0.00213	CcSEcCtD
Pentoxifylline—Drowsiness—Epirubicin—sarcoma	0.00106	0.00211	CcSEcCtD
Pentoxifylline—Infestation—Epirubicin—sarcoma	0.00106	0.00211	CcSEcCtD
Pentoxifylline—Infestation NOS—Epirubicin—sarcoma	0.00106	0.00211	CcSEcCtD
Pentoxifylline—Vomiting—Dactinomycin—sarcoma	0.00106	0.00211	CcSEcCtD
Pentoxifylline—Rash—Thiotepa—sarcoma	0.00106	0.00211	CcSEcCtD
Pentoxifylline—Dermatitis—Thiotepa—sarcoma	0.00106	0.00211	CcSEcCtD
Pentoxifylline—Headache—Thiotepa—sarcoma	0.00105	0.0021	CcSEcCtD
Pentoxifylline—Rash—Dactinomycin—sarcoma	0.00105	0.0021	CcSEcCtD
Pentoxifylline—Decreased appetite—Etoposide—sarcoma	0.00105	0.00209	CcSEcCtD
Pentoxifylline—Pancytopenia—Doxorubicin—sarcoma	0.00104	0.00208	CcSEcCtD
Pentoxifylline—Asthenia—Mitoxantrone—sarcoma	0.00104	0.00208	CcSEcCtD
Pentoxifylline—Jaundice—Epirubicin—sarcoma	0.00103	0.00206	CcSEcCtD
Pentoxifylline—Constipation—Etoposide—sarcoma	0.00103	0.00206	CcSEcCtD
Pentoxifylline—Conjunctivitis—Epirubicin—sarcoma	0.00103	0.00206	CcSEcCtD
Pentoxifylline—Diarrhoea—Vincristine—sarcoma	0.00102	0.00203	CcSEcCtD
Pentoxifylline—Sweating—Epirubicin—sarcoma	0.00102	0.00203	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Epirubicin—sarcoma	0.001	0.002	CcSEcCtD
Pentoxifylline—Epistaxis—Epirubicin—sarcoma	0.001	0.00199	CcSEcCtD
Pentoxifylline—Nausea—Thiotepa—sarcoma	0.000997	0.00199	CcSEcCtD
Pentoxifylline—Feeling abnormal—Etoposide—sarcoma	0.000994	0.00198	CcSEcCtD
Pentoxifylline—Diarrhoea—Mitoxantrone—sarcoma	0.000992	0.00198	CcSEcCtD
Pentoxifylline—Nausea—Dactinomycin—sarcoma	0.00099	0.00197	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Etoposide—sarcoma	0.000986	0.00197	CcSEcCtD
Pentoxifylline—Dizziness—Vincristine—sarcoma	0.000984	0.00196	CcSEcCtD
Pentoxifylline—Infestation NOS—Doxorubicin—sarcoma	0.000981	0.00196	CcSEcCtD
Pentoxifylline—Infestation—Doxorubicin—sarcoma	0.000981	0.00196	CcSEcCtD
Pentoxifylline—Drowsiness—Doxorubicin—sarcoma	0.000981	0.00196	CcSEcCtD
Pentoxifylline—Urticaria—Etoposide—sarcoma	0.000958	0.00191	CcSEcCtD
Pentoxifylline—Haemoglobin—Epirubicin—sarcoma	0.000956	0.00191	CcSEcCtD
Pentoxifylline—Jaundice—Doxorubicin—sarcoma	0.000956	0.00191	CcSEcCtD
Pentoxifylline—Abdominal pain—Etoposide—sarcoma	0.000953	0.0019	CcSEcCtD
Pentoxifylline—Body temperature increased—Etoposide—sarcoma	0.000953	0.0019	CcSEcCtD
Pentoxifylline—Conjunctivitis—Doxorubicin—sarcoma	0.000953	0.0019	CcSEcCtD
Pentoxifylline—Hepatitis—Epirubicin—sarcoma	0.000951	0.0019	CcSEcCtD
Pentoxifylline—Haemorrhage—Epirubicin—sarcoma	0.000951	0.0019	CcSEcCtD
Pentoxifylline—Vomiting—Vincristine—sarcoma	0.000946	0.00189	CcSEcCtD
Pentoxifylline—Sweating—Doxorubicin—sarcoma	0.00094	0.00188	CcSEcCtD
Pentoxifylline—Rash—Vincristine—sarcoma	0.000939	0.00187	CcSEcCtD
Pentoxifylline—Dermatitis—Vincristine—sarcoma	0.000938	0.00187	CcSEcCtD
Pentoxifylline—Headache—Vincristine—sarcoma	0.000933	0.00186	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Doxorubicin—sarcoma	0.000927	0.00185	CcSEcCtD
Pentoxifylline—Epistaxis—Doxorubicin—sarcoma	0.000925	0.00185	CcSEcCtD
Pentoxifylline—Vomiting—Mitoxantrone—sarcoma	0.000922	0.00184	CcSEcCtD
Pentoxifylline—Rash—Mitoxantrone—sarcoma	0.000914	0.00182	CcSEcCtD
Pentoxifylline—Dermatitis—Mitoxantrone—sarcoma	0.000913	0.00182	CcSEcCtD
Pentoxifylline—Headache—Mitoxantrone—sarcoma	0.000908	0.00181	CcSEcCtD
Pentoxifylline—Hypersensitivity—Etoposide—sarcoma	0.000888	0.00177	CcSEcCtD
Pentoxifylline—Haemoglobin—Doxorubicin—sarcoma	0.000885	0.00177	CcSEcCtD
Pentoxifylline—Nausea—Vincristine—sarcoma	0.000884	0.00176	CcSEcCtD
Pentoxifylline—Flushing—Epirubicin—sarcoma	0.000883	0.00176	CcSEcCtD
Pentoxifylline—Hepatitis—Doxorubicin—sarcoma	0.00088	0.00176	CcSEcCtD
Pentoxifylline—Haemorrhage—Doxorubicin—sarcoma	0.00088	0.00176	CcSEcCtD
Pentoxifylline—Asthenia—Etoposide—sarcoma	0.000865	0.00173	CcSEcCtD
Pentoxifylline—Nausea—Mitoxantrone—sarcoma	0.000861	0.00172	CcSEcCtD
Pentoxifylline—Immune system disorder—Epirubicin—sarcoma	0.000859	0.00171	CcSEcCtD
Pentoxifylline—Pruritus—Etoposide—sarcoma	0.000853	0.0017	CcSEcCtD
Pentoxifylline—Arrhythmia—Epirubicin—sarcoma	0.00085	0.0017	CcSEcCtD
Pentoxifylline—Erythema—Epirubicin—sarcoma	0.000828	0.00165	CcSEcCtD
Pentoxifylline—Diarrhoea—Etoposide—sarcoma	0.000825	0.00165	CcSEcCtD
Pentoxifylline—Flushing—Doxorubicin—sarcoma	0.000817	0.00163	CcSEcCtD
Pentoxifylline—Flatulence—Epirubicin—sarcoma	0.000816	0.00163	CcSEcCtD
Pentoxifylline—Tension—Epirubicin—sarcoma	0.000813	0.00162	CcSEcCtD
Pentoxifylline—Dysgeusia—Epirubicin—sarcoma	0.000811	0.00162	CcSEcCtD
Pentoxifylline—Nervousness—Epirubicin—sarcoma	0.000804	0.0016	CcSEcCtD
Pentoxifylline—Back pain—Epirubicin—sarcoma	0.000801	0.0016	CcSEcCtD
Pentoxifylline—Dizziness—Etoposide—sarcoma	0.000797	0.00159	CcSEcCtD
Pentoxifylline—Muscle spasms—Epirubicin—sarcoma	0.000796	0.00159	CcSEcCtD
Pentoxifylline—Immune system disorder—Doxorubicin—sarcoma	0.000795	0.00159	CcSEcCtD
Pentoxifylline—Arrhythmia—Doxorubicin—sarcoma	0.000786	0.00157	CcSEcCtD
Pentoxifylline—Vision blurred—Epirubicin—sarcoma	0.000781	0.00156	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Epirubicin—sarcoma	0.000768	0.00153	CcSEcCtD
Pentoxifylline—Vomiting—Etoposide—sarcoma	0.000767	0.00153	CcSEcCtD
Pentoxifylline—Erythema—Doxorubicin—sarcoma	0.000766	0.00153	CcSEcCtD
Pentoxifylline—Anaemia—Epirubicin—sarcoma	0.000765	0.00153	CcSEcCtD
Pentoxifylline—Agitation—Epirubicin—sarcoma	0.000761	0.00152	CcSEcCtD
Pentoxifylline—Rash—Etoposide—sarcoma	0.00076	0.00152	CcSEcCtD
Pentoxifylline—Dermatitis—Etoposide—sarcoma	0.00076	0.00152	CcSEcCtD
Pentoxifylline—Headache—Etoposide—sarcoma	0.000755	0.00151	CcSEcCtD
Pentoxifylline—Flatulence—Doxorubicin—sarcoma	0.000755	0.00151	CcSEcCtD
Pentoxifylline—Tension—Doxorubicin—sarcoma	0.000752	0.0015	CcSEcCtD
Pentoxifylline—Dysgeusia—Doxorubicin—sarcoma	0.00075	0.0015	CcSEcCtD
Pentoxifylline—Malaise—Epirubicin—sarcoma	0.000747	0.00149	CcSEcCtD
Pentoxifylline—Nervousness—Doxorubicin—sarcoma	0.000744	0.00148	CcSEcCtD
Pentoxifylline—Leukopenia—Epirubicin—sarcoma	0.000741	0.00148	CcSEcCtD
Pentoxifylline—Back pain—Doxorubicin—sarcoma	0.000741	0.00148	CcSEcCtD
Pentoxifylline—Muscle spasms—Doxorubicin—sarcoma	0.000737	0.00147	CcSEcCtD
Pentoxifylline—Palpitations—Epirubicin—sarcoma	0.000732	0.00146	CcSEcCtD
Pentoxifylline—Vision blurred—Doxorubicin—sarcoma	0.000722	0.00144	CcSEcCtD
Pentoxifylline—Convulsion—Epirubicin—sarcoma	0.000718	0.00143	CcSEcCtD
Pentoxifylline—Nausea—Etoposide—sarcoma	0.000716	0.00143	CcSEcCtD
Pentoxifylline—Hypertension—Epirubicin—sarcoma	0.000715	0.00143	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Doxorubicin—sarcoma	0.000711	0.00142	CcSEcCtD
Pentoxifylline—Anaemia—Doxorubicin—sarcoma	0.000708	0.00141	CcSEcCtD
Pentoxifylline—Chest pain—Epirubicin—sarcoma	0.000705	0.00141	CcSEcCtD
Pentoxifylline—Myalgia—Epirubicin—sarcoma	0.000705	0.00141	CcSEcCtD
Pentoxifylline—Agitation—Doxorubicin—sarcoma	0.000704	0.0014	CcSEcCtD
Pentoxifylline—Anxiety—Epirubicin—sarcoma	0.000703	0.0014	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.0007	0.0014	CcSEcCtD
Pentoxifylline—Discomfort—Epirubicin—sarcoma	0.000697	0.00139	CcSEcCtD
Pentoxifylline—Malaise—Doxorubicin—sarcoma	0.000691	0.00138	CcSEcCtD
Pentoxifylline—Dry mouth—Epirubicin—sarcoma	0.00069	0.00138	CcSEcCtD
Pentoxifylline—Leukopenia—Doxorubicin—sarcoma	0.000686	0.00137	CcSEcCtD
Pentoxifylline—Confusional state—Epirubicin—sarcoma	0.000682	0.00136	CcSEcCtD
Pentoxifylline—Palpitations—Doxorubicin—sarcoma	0.000677	0.00135	CcSEcCtD
Pentoxifylline—Oedema—Epirubicin—sarcoma	0.000676	0.00135	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Epirubicin—sarcoma	0.000676	0.00135	CcSEcCtD
Pentoxifylline—Infection—Epirubicin—sarcoma	0.000671	0.00134	CcSEcCtD
Pentoxifylline—Shock—Epirubicin—sarcoma	0.000665	0.00133	CcSEcCtD
Pentoxifylline—Convulsion—Doxorubicin—sarcoma	0.000664	0.00132	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Epirubicin—sarcoma	0.000662	0.00132	CcSEcCtD
Pentoxifylline—Hypertension—Doxorubicin—sarcoma	0.000662	0.00132	CcSEcCtD
Pentoxifylline—Tachycardia—Epirubicin—sarcoma	0.00066	0.00132	CcSEcCtD
Pentoxifylline—Skin disorder—Epirubicin—sarcoma	0.000657	0.00131	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Epirubicin—sarcoma	0.000653	0.0013	CcSEcCtD
Pentoxifylline—Chest pain—Doxorubicin—sarcoma	0.000652	0.0013	CcSEcCtD
Pentoxifylline—Myalgia—Doxorubicin—sarcoma	0.000652	0.0013	CcSEcCtD
Pentoxifylline—Anxiety—Doxorubicin—sarcoma	0.00065	0.0013	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000648	0.00129	CcSEcCtD
Pentoxifylline—Discomfort—Doxorubicin—sarcoma	0.000645	0.00129	CcSEcCtD
Pentoxifylline—Anorexia—Epirubicin—sarcoma	0.000644	0.00129	CcSEcCtD
Pentoxifylline—Dry mouth—Doxorubicin—sarcoma	0.000638	0.00127	CcSEcCtD
Pentoxifylline—Hypotension—Epirubicin—sarcoma	0.000632	0.00126	CcSEcCtD
Pentoxifylline—Confusional state—Doxorubicin—sarcoma	0.000631	0.00126	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Doxorubicin—sarcoma	0.000625	0.00125	CcSEcCtD
Pentoxifylline—Oedema—Doxorubicin—sarcoma	0.000625	0.00125	CcSEcCtD
Pentoxifylline—Infection—Doxorubicin—sarcoma	0.000621	0.00124	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000616	0.00123	CcSEcCtD
Pentoxifylline—Shock—Doxorubicin—sarcoma	0.000615	0.00123	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Doxorubicin—sarcoma	0.000612	0.00122	CcSEcCtD
Pentoxifylline—Insomnia—Epirubicin—sarcoma	0.000611	0.00122	CcSEcCtD
Pentoxifylline—Tachycardia—Doxorubicin—sarcoma	0.00061	0.00122	CcSEcCtD
Pentoxifylline—Skin disorder—Doxorubicin—sarcoma	0.000607	0.00121	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Doxorubicin—sarcoma	0.000605	0.00121	CcSEcCtD
Pentoxifylline—Dyspnoea—Epirubicin—sarcoma	0.000603	0.0012	CcSEcCtD
Pentoxifylline—Somnolence—Epirubicin—sarcoma	0.000601	0.0012	CcSEcCtD
Pentoxifylline—Anorexia—Doxorubicin—sarcoma	0.000596	0.00119	CcSEcCtD
Pentoxifylline—Dyspepsia—Epirubicin—sarcoma	0.000595	0.00119	CcSEcCtD
Pentoxifylline—Decreased appetite—Epirubicin—sarcoma	0.000588	0.00117	CcSEcCtD
Pentoxifylline—Hypotension—Doxorubicin—sarcoma	0.000584	0.00117	CcSEcCtD
Pentoxifylline—Constipation—Epirubicin—sarcoma	0.000578	0.00115	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00057	0.00114	CcSEcCtD
Pentoxifylline—Insomnia—Doxorubicin—sarcoma	0.000566	0.00113	CcSEcCtD
Pentoxifylline—Dyspnoea—Doxorubicin—sarcoma	0.000558	0.00111	CcSEcCtD
Pentoxifylline—Feeling abnormal—Epirubicin—sarcoma	0.000557	0.00111	CcSEcCtD
Pentoxifylline—Somnolence—Doxorubicin—sarcoma	0.000556	0.00111	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Epirubicin—sarcoma	0.000553	0.0011	CcSEcCtD
Pentoxifylline—Dyspepsia—Doxorubicin—sarcoma	0.000551	0.0011	CcSEcCtD
Pentoxifylline—Decreased appetite—Doxorubicin—sarcoma	0.000544	0.00108	CcSEcCtD
Pentoxifylline—Urticaria—Epirubicin—sarcoma	0.000537	0.00107	CcSEcCtD
Pentoxifylline—Constipation—Doxorubicin—sarcoma	0.000535	0.00107	CcSEcCtD
Pentoxifylline—Abdominal pain—Epirubicin—sarcoma	0.000534	0.00107	CcSEcCtD
Pentoxifylline—Body temperature increased—Epirubicin—sarcoma	0.000534	0.00107	CcSEcCtD
Pentoxifylline—Feeling abnormal—Doxorubicin—sarcoma	0.000515	0.00103	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Doxorubicin—sarcoma	0.000511	0.00102	CcSEcCtD
Pentoxifylline—Hypersensitivity—Epirubicin—sarcoma	0.000498	0.000994	CcSEcCtD
Pentoxifylline—Urticaria—Doxorubicin—sarcoma	0.000497	0.000991	CcSEcCtD
Pentoxifylline—Body temperature increased—Doxorubicin—sarcoma	0.000494	0.000986	CcSEcCtD
Pentoxifylline—Abdominal pain—Doxorubicin—sarcoma	0.000494	0.000986	CcSEcCtD
Pentoxifylline—Asthenia—Epirubicin—sarcoma	0.000485	0.000968	CcSEcCtD
Pentoxifylline—Pruritus—Epirubicin—sarcoma	0.000478	0.000954	CcSEcCtD
Pentoxifylline—Diarrhoea—Epirubicin—sarcoma	0.000462	0.000923	CcSEcCtD
Pentoxifylline—Hypersensitivity—Doxorubicin—sarcoma	0.000461	0.000919	CcSEcCtD
Pentoxifylline—Asthenia—Doxorubicin—sarcoma	0.000449	0.000895	CcSEcCtD
Pentoxifylline—Dizziness—Epirubicin—sarcoma	0.000447	0.000892	CcSEcCtD
Pentoxifylline—Pruritus—Doxorubicin—sarcoma	0.000442	0.000883	CcSEcCtD
Pentoxifylline—Vomiting—Epirubicin—sarcoma	0.00043	0.000857	CcSEcCtD
Pentoxifylline—Diarrhoea—Doxorubicin—sarcoma	0.000428	0.000854	CcSEcCtD
Pentoxifylline—Rash—Epirubicin—sarcoma	0.000426	0.00085	CcSEcCtD
Pentoxifylline—Dermatitis—Epirubicin—sarcoma	0.000426	0.000849	CcSEcCtD
Pentoxifylline—Headache—Epirubicin—sarcoma	0.000423	0.000845	CcSEcCtD
Pentoxifylline—Dizziness—Doxorubicin—sarcoma	0.000414	0.000825	CcSEcCtD
Pentoxifylline—Nausea—Epirubicin—sarcoma	0.000401	0.000801	CcSEcCtD
Pentoxifylline—Vomiting—Doxorubicin—sarcoma	0.000398	0.000793	CcSEcCtD
Pentoxifylline—Rash—Doxorubicin—sarcoma	0.000394	0.000787	CcSEcCtD
Pentoxifylline—Dermatitis—Doxorubicin—sarcoma	0.000394	0.000786	CcSEcCtD
Pentoxifylline—Headache—Doxorubicin—sarcoma	0.000392	0.000782	CcSEcCtD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—ATF1—sarcoma	0.000388	0.00691	CbGpPWpGaD
Pentoxifylline—CYP1A2—Melatonin metabolism and effects—FOXO1—sarcoma	0.000386	0.00687	CbGpPWpGaD
Pentoxifylline—CYP1A2—Estrogen Receptor Pathway—JUN—sarcoma	0.000382	0.00681	CbGpPWpGaD
Pentoxifylline—ADORA2B—C-MYB transcription factor network—MYC—sarcoma	0.000379	0.00676	CbGpPWpGaD
Pentoxifylline—Nausea—Doxorubicin—sarcoma	0.000371	0.000741	CcSEcCtD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.000364	0.00648	CbGpPWpGaD
Pentoxifylline—ADORA2B—C-MYB transcription factor network—KRAS—sarcoma	0.00035	0.00624	CbGpPWpGaD
Pentoxifylline—PDE4A—G Protein Signaling Pathways—NRAS—sarcoma	0.000341	0.00607	CbGpPWpGaD
Pentoxifylline—PDE4B—Myometrial Relaxation and Contraction Pathways—CREB1—sarcoma	0.000338	0.00602	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—CXCR4—sarcoma	0.000328	0.00584	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—CXCR4—sarcoma	0.000326	0.0058	CbGpPWpGaD
Pentoxifylline—PDE4B—G Protein Signaling Pathways—NRAS—sarcoma	0.000315	0.00562	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—PLCG1—sarcoma	0.000314	0.00559	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—ATF1—sarcoma	0.000298	0.00531	CbGpPWpGaD
Pentoxifylline—ADORA2B—C-MYB transcription factor network—HRAS—sarcoma	0.000298	0.00531	CbGpPWpGaD
Pentoxifylline—PDE4A—G Protein Signaling Pathways—KRAS—sarcoma	0.000293	0.00523	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—FOXO1—sarcoma	0.00029	0.00516	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—PDGFRB—sarcoma	0.000289	0.00515	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—ENO2—sarcoma	0.000286	0.0051	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—PDGFRA—sarcoma	0.000285	0.00507	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—HBA1—sarcoma	0.000285	0.00507	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.000281	0.005	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—CREB1—sarcoma	0.000278	0.00494	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—CXCR4—sarcoma	0.000277	0.00493	CbGpPWpGaD
Pentoxifylline—PDE4B—G Protein Signaling Pathways—KRAS—sarcoma	0.000271	0.00483	CbGpPWpGaD
Pentoxifylline—PDE4A—G Protein Signaling Pathways—HRAS—sarcoma	0.000249	0.00444	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—PLCG1—sarcoma	0.000243	0.00433	CbGpPWpGaD
Pentoxifylline—PDE4B—Myometrial Relaxation and Contraction Pathways—JUN—sarcoma	0.000243	0.00433	CbGpPWpGaD
Pentoxifylline—PDE4B—G Protein Signaling Pathways—HRAS—sarcoma	0.000231	0.00411	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—FOXO1—sarcoma	0.000223	0.00397	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—PDGFRB—sarcoma	0.000222	0.00396	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—KIT—sarcoma	0.000221	0.00393	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—PDGFRA—sarcoma	0.000219	0.0039	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—CREB1—sarcoma	0.000214	0.00382	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—CXCR4—sarcoma	0.000214	0.00381	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—CREB1—sarcoma	0.00021	0.00374	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—JUN—sarcoma	0.0002	0.00356	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—CXCR4—sarcoma	0.000184	0.00328	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—MDM2—sarcoma	0.000174	0.0031	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—IL2—sarcoma	0.000173	0.00308	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—KIT—sarcoma	0.00017	0.00302	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—CXCR4—sarcoma	0.000167	0.00298	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—CXCR4—sarcoma	0.000167	0.00298	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—CREB1—sarcoma	0.000162	0.00288	CbGpPWpGaD
Pentoxifylline—CYP1A2—Tryptophan metabolism—MDM2—sarcoma	0.00016	0.00285	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—CXCR4—sarcoma	0.000156	0.00279	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TLE1—sarcoma	0.000155	0.00276	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—CXCR4—sarcoma	0.000155	0.00275	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—JUN—sarcoma	0.000154	0.00275	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CXCR4—sarcoma	0.000152	0.0027	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—SRC—sarcoma	0.000151	0.00269	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—VEGFA—sarcoma	0.000147	0.00262	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—NRAS—sarcoma	0.000145	0.00258	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	0.000143	0.00255	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CXCR4—sarcoma	0.000142	0.00253	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TLE1—sarcoma	0.000141	0.00251	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CXCR4—sarcoma	0.00014	0.0025	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	0.000139	0.00248	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—SRC—sarcoma	0.000136	0.00241	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—MDM2—sarcoma	0.000134	0.00238	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TLE1—sarcoma	0.000132	0.00235	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—TP53—sarcoma	0.000132	0.00235	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—VEGFC—sarcoma	0.000131	0.00233	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—NRAS—sarcoma	0.00013	0.00232	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TLE1—sarcoma	0.00013	0.00232	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—KRAS—sarcoma	0.000125	0.00222	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—SRC—sarcoma	0.000125	0.00222	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	0.000125	0.00222	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	0.000122	0.00217	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CXCR4—sarcoma	0.000121	0.00215	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—sarcoma	0.00012	0.00214	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—sarcoma	0.000119	0.00212	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—VEGFC—sarcoma	0.000119	0.00212	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—KRAS—sarcoma	0.000112	0.002	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—MYC—sarcoma	0.000112	0.00199	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—VEGFC—sarcoma	0.000111	0.00198	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—TP53—sarcoma	0.000111	0.00198	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—VEGFC—sarcoma	0.00011	0.00196	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CXCR4—sarcoma	0.00011	0.00195	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	0.000109	0.00195	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—sarcoma	0.000109	0.00195	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—HRAS—sarcoma	0.000106	0.00189	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—FLT1—sarcoma	0.000105	0.00186	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—SRC—sarcoma	0.000104	0.00186	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—sarcoma	0.000103	0.00184	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PLCG1—sarcoma	0.000103	0.00183	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TLE1—sarcoma	0.000102	0.00181	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—TP53—sarcoma	0.000102	0.00181	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—NRAS—sarcoma	0.0001	0.00179	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CXCR4—sarcoma	9.87e-05	0.00176	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ATF1—sarcoma	9.76e-05	0.00174	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—sarcoma	9.54e-05	0.0017	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—FLT1—sarcoma	9.49e-05	0.00169	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PLCG1—sarcoma	9.33e-05	0.00166	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—EGFR—sarcoma	9.14e-05	0.00163	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CXCR4—sarcoma	8.96e-05	0.0016	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—CREB1—sarcoma	8.95e-05	0.00159	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—FLT1—sarcoma	8.89e-05	0.00158	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ATF1—sarcoma	8.86e-05	0.00158	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—sarcoma	8.79e-05	0.00157	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—FLT1—sarcoma	8.78e-05	0.00156	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PLCG1—sarcoma	8.74e-05	0.00156	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—KRAS—sarcoma	8.63e-05	0.00154	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PLCG1—sarcoma	8.63e-05	0.00154	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—VEGFC—sarcoma	8.58e-05	0.00153	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CXCR4—sarcoma	8.39e-05	0.0015	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ATF1—sarcoma	8.3e-05	0.00148	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CXCR4—sarcoma	8.29e-05	0.00148	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ATF1—sarcoma	8.2e-05	0.00146	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CREB1—sarcoma	8.13e-05	0.00145	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IGF1R—sarcoma	7.66e-05	0.00136	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CREB1—sarcoma	7.61e-05	0.00136	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CREB1—sarcoma	7.52e-05	0.00134	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—HRAS—sarcoma	7.34e-05	0.00131	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—FOXO1—sarcoma	7.29e-05	0.0013	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—IL2—sarcoma	7.29e-05	0.0013	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PDGFRB—sarcoma	7.28e-05	0.0013	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PDGFRA—sarcoma	7.16e-05	0.00128	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IGF1R—sarcoma	6.95e-05	0.00124	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FLT1—sarcoma	6.86e-05	0.00122	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PLCG1—sarcoma	6.75e-05	0.0012	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—FOXO1—sarcoma	6.62e-05	0.00118	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL2—sarcoma	6.62e-05	0.00118	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—IL2—sarcoma	6.62e-05	0.00118	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PDGFRB—sarcoma	6.61e-05	0.00118	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IGF1R—sarcoma	6.51e-05	0.00116	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PDGFRA—sarcoma	6.51e-05	0.00116	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CXCR4—sarcoma	6.48e-05	0.00115	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IGF1R—sarcoma	6.44e-05	0.00115	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ATF1—sarcoma	6.41e-05	0.00114	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—FOXO1—sarcoma	6.2e-05	0.0011	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—IL2—sarcoma	6.2e-05	0.0011	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PDGFRB—sarcoma	6.19e-05	0.0011	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—FOXO1—sarcoma	6.13e-05	0.00109	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—IL2—sarcoma	6.12e-05	0.00109	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PDGFRB—sarcoma	6.11e-05	0.00109	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PDGFRA—sarcoma	6.09e-05	0.00109	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—KDR—sarcoma	6.03e-05	0.00107	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PDGFRA—sarcoma	6.02e-05	0.00107	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL2—sarcoma	6.01e-05	0.00107	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CREB1—sarcoma	5.88e-05	0.00105	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL2—sarcoma	5.63e-05	0.001	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL2—sarcoma	5.56e-05	0.00099	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—KIT—sarcoma	5.55e-05	0.00099	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—NRAS—sarcoma	5.55e-05	0.00099	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—KDR—sarcoma	5.48e-05	0.000975	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CREB1—sarcoma	5.29e-05	0.000942	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—KDR—sarcoma	5.13e-05	0.000913	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—KDR—sarcoma	5.07e-05	0.000903	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—EGFR—sarcoma	5.06e-05	0.000902	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—KIT—sarcoma	5.04e-05	0.000899	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—NRAS—sarcoma	5.04e-05	0.000899	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IGF1R—sarcoma	5.03e-05	0.000896	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CREB1—sarcoma	4.8e-05	0.000855	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FOXO1—sarcoma	4.79e-05	0.000853	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—IL2—sarcoma	4.78e-05	0.000852	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—KRAS—sarcoma	4.78e-05	0.000852	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PDGFRB—sarcoma	4.78e-05	0.000851	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—KIT—sarcoma	4.72e-05	0.000841	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—NRAS—sarcoma	4.72e-05	0.000841	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PDGFRA—sarcoma	4.7e-05	0.000838	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—KIT—sarcoma	4.67e-05	0.000831	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—NRAS—sarcoma	4.67e-05	0.000831	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—EGFR—sarcoma	4.6e-05	0.000819	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CREB1—sarcoma	4.5e-05	0.000801	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CREB1—sarcoma	4.44e-05	0.000791	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MDM2—sarcoma	4.37e-05	0.000779	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL2—sarcoma	4.34e-05	0.000774	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—KRAS—sarcoma	4.34e-05	0.000773	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—EGFR—sarcoma	4.3e-05	0.000767	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—EGFR—sarcoma	4.25e-05	0.000758	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—KRAS—sarcoma	4.07e-05	0.000724	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—HRAS—sarcoma	4.06e-05	0.000724	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—KRAS—sarcoma	4.02e-05	0.000716	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MDM2—sarcoma	3.97e-05	0.000708	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—KDR—sarcoma	3.96e-05	0.000705	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL2—sarcoma	3.91e-05	0.000696	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCND1—sarcoma	3.81e-05	0.000679	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—JUN—sarcoma	3.8e-05	0.000677	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CTNNB1—sarcoma	3.77e-05	0.000672	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MDM2—sarcoma	3.72e-05	0.000663	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—HRAS—sarcoma	3.69e-05	0.000657	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MDM2—sarcoma	3.68e-05	0.000655	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—KIT—sarcoma	3.65e-05	0.00065	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—NRAS—sarcoma	3.65e-05	0.00065	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL2—sarcoma	3.55e-05	0.000632	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CREB1—sarcoma	3.47e-05	0.000618	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCND1—sarcoma	3.46e-05	0.000616	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—HRAS—sarcoma	3.46e-05	0.000616	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—JUN—sarcoma	3.45e-05	0.000615	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CTNNB1—sarcoma	3.43e-05	0.00061	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—HRAS—sarcoma	3.41e-05	0.000608	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SRC—sarcoma	3.41e-05	0.000608	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL2—sarcoma	3.32e-05	0.000592	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—EGFR—sarcoma	3.32e-05	0.000592	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—VEGFA—sarcoma	3.32e-05	0.000592	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL2—sarcoma	3.28e-05	0.000585	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NRAS—sarcoma	3.28e-05	0.000585	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCND1—sarcoma	3.24e-05	0.000577	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—JUN—sarcoma	3.23e-05	0.000576	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CTNNB1—sarcoma	3.21e-05	0.000572	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCND1—sarcoma	3.2e-05	0.00057	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—JUN—sarcoma	3.19e-05	0.000569	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CTNNB1—sarcoma	3.17e-05	0.000565	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—KRAS—sarcoma	3.14e-05	0.000559	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SRC—sarcoma	3.1e-05	0.000552	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MYC—sarcoma	3.06e-05	0.000545	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—VEGFA—sarcoma	3.02e-05	0.000537	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—EGFR—sarcoma	2.99e-05	0.000533	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NRAS—sarcoma	2.98e-05	0.000531	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SRC—sarcoma	2.9e-05	0.000517	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MDM2—sarcoma	2.87e-05	0.000512	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SRC—sarcoma	2.87e-05	0.000511	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—VEGFA—sarcoma	2.82e-05	0.000503	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—KRAS—sarcoma	2.82e-05	0.000503	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—VEGFA—sarcoma	2.79e-05	0.000497	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NRAS—sarcoma	2.79e-05	0.000497	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MYC—sarcoma	2.78e-05	0.000494	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NRAS—sarcoma	2.76e-05	0.000491	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—EGFR—sarcoma	2.71e-05	0.000484	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—HRAS—sarcoma	2.67e-05	0.000475	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ENO2—sarcoma	2.64e-05	0.00047	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—HBA1—sarcoma	2.62e-05	0.000467	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MYC—sarcoma	2.6e-05	0.000463	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MYC—sarcoma	2.57e-05	0.000458	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL2—sarcoma	2.57e-05	0.000457	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—KRAS—sarcoma	2.56e-05	0.000457	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—EGFR—sarcoma	2.54e-05	0.000453	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—EGFR—sarcoma	2.51e-05	0.000447	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TP53—sarcoma	2.51e-05	0.000447	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCND1—sarcoma	2.5e-05	0.000446	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—JUN—sarcoma	2.5e-05	0.000445	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CTNNB1—sarcoma	2.48e-05	0.000441	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—KRAS—sarcoma	2.4e-05	0.000428	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HRAS—sarcoma	2.4e-05	0.000428	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—KRAS—sarcoma	2.37e-05	0.000423	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TP53—sarcoma	2.28e-05	0.000406	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SRC—sarcoma	2.24e-05	0.000399	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PLCG1—sarcoma	2.24e-05	0.000399	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—VEGFA—sarcoma	2.18e-05	0.000389	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HRAS—sarcoma	2.18e-05	0.000388	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NRAS—sarcoma	2.15e-05	0.000384	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TP53—sarcoma	2.13e-05	0.00038	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TP53—sarcoma	2.11e-05	0.000376	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HRAS—sarcoma	2.04e-05	0.000364	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HRAS—sarcoma	2.02e-05	0.000359	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MYC—sarcoma	2.01e-05	0.000357	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EGFR—sarcoma	1.96e-05	0.00035	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—KRAS—sarcoma	1.85e-05	0.00033	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TP53—sarcoma	1.65e-05	0.000294	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HRAS—sarcoma	1.58e-05	0.000281	CbGpPWpGaD
